Send us Feedback

Monogram Biosciences (MGRM)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Hedge Fund Trader Banned For Manipulating Stock Prices
Hedge Fund Blogs From HedgeCo.Net  Jun 30  Comment 
The Financial Industry Regulatory Authority (FINRA) has permanently barred a former Deutsche Bank broker from the securities industry for manipulating the price of Monogram Biosciences (MGRM) stock in an effort to enrich a hedge fund client,...
Greenwich Deutsche Bank Broker Barred For Manipulating Shares Of MGRM (DB, MGRM)
Clusterstock  Jun 29  Comment 
FINRA just banned a Deutsche Bank broker, Edward Brokaw, who they say manipulated MGRM (Monogram Biosciences) stock on purpose in order to make money off trades for his family and an unnamed hedge fund client. First, the background, according to...
The Best Investing Ideas in Health Care
Motley Fool  Feb 22  Comment 
Tracking market monthly trends can lead to great investment ideas, and shed new light on stocks already in your portfolio.
Don't Fear Obamacare
Forbes  Oct 29  Comment 
Some health care stocks are poised for gains no matter what happens in D.C.
Potent HIV-Blocking Proteins Raise Hopes for Vaccine
Bloomberg  Sep 3  Comment 
(Update2) A new blood screening technique has turned up antibodies with the ability to neutralize many strains of the AIDS virus, a discovery that might help create a long- sought vaccine against the deadly disease.
LabCorp commences tender offer for Monogram
MarketWatch  Jul 1  Comment 
Laboratory Corp. of America said Wednesday that it has commenced its previously announced tender offer for all the outstanding shares of Monogram Biosciences . Under the terms of the deal, LabCorp is offering $4.55 in cash per Monogram share....
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Monogram Biosciences, Inc.
Marketwire  Jun 30  Comment 
BALA CYNWYD, PA -- (Marketwire) -- 06/30/09 -- Law office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed in the Superior Court of California challenging the proposed acquisition of Monogram Biosciences, Inc. ("Monogram
LabCorp scoops up Monogram Biosciences for $106M
FierceBiotech  Jun 23  Comment 
LabCorp has struck a deal to buy Monogram Biosciences for $106.7 million, a deal that will give the company a new set of tools used in drug discovery work. The acquisition today also highlights LabCorp's rapid expansion as it continues on a buyout...
LabCorp to buy Monogram Biosciences for $106.7 mln
Reuters  Jun 23  Comment 




RELATED WIKI ARTICLES

Related Articles

more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Grant Zeng
www.zacks.com

Monogram Biosciences is a life sciences company committed to advancing personalized medicine and improving patient outcomes through the development of innovative products that guide and target the most appropriate treatments. Through a comprehensive understanding of genetic structures and the biology and pathology of disease, the company has pioneered and is developing molecular diagnostics and laboratory services that are intended to:

enable physicians to better manage infectious diseases and cancer by providing the critical information that helps them prescribe personalized treatment for patients by matching the underlying molecular features of an individual patient's disease to the drug expected to have maximal therapeutic benefit

enable pharmaceutical companies to develop new and improved anti-viral therapeutics and targeted cancer therapeutics while minimizing development costs by accelerating the progress of existing drugs in development through clinical trials.

Over the last several years, the company has built a business based on the personalized medicine approach in HIV drug resistance testing. Through its merger with Aclara BioSciences, Inc. in December 2004, the company intends to leverage the experience and infrastructure that it has built in the HIV market to the substantially larger market opportunity of cancer-testing products utilizing the proprietary VeraTag technology, formerly known as eTag technology. Monogram Biosciences was formerly known as ViroLogic, Inc. It changed its name to Monogram Biosciences, Inc. in 2005. The company was incorporated in Delaware in 1995 and is headquartered in South San Francisco, CA.




References

Retrieved from "http://www.wikinvest.com/stock/Monogram_Biosciences_(MGRM)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki